A few reasons
why you should
give us a trial.

When it comes to finding the right DCT partner, we know you’ve got options and that you always do your research. That’s why we invite you to get to know a bit more about what sets Delve Health apart.

FROM MINNESOTA
TO THE WORLD

Our technology helps clinical researchers quickly perform pre-screening criteria assessment, recruit patients more efficiently, and broaden overall patient diversity.

NOT OUR FIRST RODEO

We’ve supported 100+ studies and 26 registries in therapeutic areas including oncology, cardiovascular, endocrinology, dermatology, pediatric disorders, and so much more.

WIDE INDUSTRY
KNOWLEDGE

Our clients have included medical device, pharmaceutical and biotech manufacturers, CROs, as well as specific therapeutic area organizations.

DIGITAL SCREENING
& RECRUITMENT

Our technology helps clinical researchers quickly perform pre-screening criteria assessment, recruit patients more efficiently, and broaden overall patient diversity.

eCONSENT / VIDEO
CONSENT

Through a friendly digital experience, patients can review study material from the comfort of home. Our configurable tools let you account for varying regulations and protocol revisions.

WEARABLES &
CONNECTED DEVICES

Utilizing more sensitive measures than traditional clinical scales, our wearables program makes it easier for your team to conduct extended in-home studies and easier for patients to engage.

The people at
the center of our
people-centric
approach.

Our global team of experts is committed to improving hybrid
decentralized clinical studies with technology solutions that patients
want to use and researchers can trust for results. And it all starts with
our passionate experienced leadership group

WESSAM SONBOL
CO-FOUNDER & CEO

A proven biopharmaceuticals and healthcare
solutions strategist focusing on life science
process improvement, Wessam has nearly 20
years of experience in Phase I-IV, IDE and 510(K)
clinical research and healthcare business
operations. He’s successfully managed a data
management organization and worked with
Fortune 500 companies such as Medtronic,
Abbott Vascular and J&J. Through breakthrough
strategies, Wessam helps achieve notable results
in improving clinical trial outcomes.

TAMER SWIDAN
CO-FOUNDER & CTO

A proven biopharmaceuticals and healthcare
solutions strategist focusing on life science
process improvement, Wessam has nearly 20
years of experience in Phase I-IV, IDE and 510(K)
clinical research and healthcare business
operations. He’s successfully managed a data
management organization and worked with
Fortune 500 companies such as Medtronic,
Abbott Vascular and J&J. Through breakthrough
strategies, Wessam helps achieve notable results
in improving clinical trial outcomes.

DAVE ALDERSON
VP OF BUSINESS DEVELOPMENT

Of his 30 years of experience, Dave spent ten leading product development for MRI, PET and other diagnostic and treatment devices. Since then, he’s assembled and managed sales teams for custom and commercial software systems and related services to support and enhance clinical development. A frequent speaker and author on various clinical topics, Dave specializes in bringing the power of clinical systems to early- and late-stage development.

Let’s talk about
your trial.

Want to see how our technology and team of experts can help
reduce costs while boosting collaboration, compliance and
inclusion? Drop us a note to start a conversation.